ASC Case Volume Mix as a Percent of Total Cases

Here is a breakdown of the case volume mix as a percent of an ASC’s total cases from the VMG Health 2009 Intellimarker. Analysis is provided for the average of all surveyed facilities; facilities with a net revenue of less than $4.5 million; facilities with net revenue from $4.5 million to less than $7 million; and facilities with net revenue of $7 million and higher.

Advertisement


All facilities

  • GI/Endoscopy — 25 percent
  • Ophthalmology — 18 percent
  • Pain management — 17 percent
  • Orthopedics — 16 percent
  • General surgery — 8 percent
  • ENT — 7 percent
  • OB/GYN — 4 percent
  • Plastic surgery — 4 percent
  • Podiatry — 4 percent
  • Urology — 3 percent
  • Oral surgery — 1 percent
  • Other — 1 percent

> $4.5 million

  • GI/Endoscopy — 29 percent
  • Ophthalmology — 24 percent
  • Orthopedics — 16 percent
  • Pain management — 15 percent
  • General surgery — 10 percent
  • Plastic surgery — 6 percent
  • ENT — 5 percent
  • Podiatry — 5 percent
  • Urology — 4 percent
  • Other — 3 percent
  • OB/GYN — 2 percent
  • Oral surgery — 1 percent

$4.5 million–<$7 million

  • GI/Endoscopy — 20 percent
  • Pain management — 16 percent
  • Orthopedics — 16 percent
  • Ophthalmology — 14 percent
  • General surgery — 8 percent
  • ENT — 7 percent
  • Plastic surgery — 5 percent
  • Urology — 4 percent
  • OB/GYN — 3 percent
  • Podiatry — 3 percent
  • Oral surgery — 1 percent
  • Other — 1 percent

$7 million and higher

  • GI/Endoscopy — 21 percent
  • Pain management — 18 percent
  • Orthopedics — 16 percent
  • Ophthalmology — 13 percent
  • ENT — 8 percent
  • General surgery — 6 percent
  • OB/GYN — 6 percent
  • Plastic surgery — 4 percent
  • Podiatry — 3 percent
  • Urology — 2 percent
  • Oral surgery — 1 percent


Information comes from VMG Health’s 2009 Intellimarker benchmarking study. VMG Health is a leading valuation and transaction advisory firm in healthcare. To receive a complimentary copy of VMG Health’s 2009 Intellimarker, click here.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.